Stocks and Investing Stocks and Investing
Mon, July 26, 2021

Judah Frommer Initiated (ABOS) at Buy and Held Target at $26 on, Jul 26th, 2021


Published on 2024-10-27 17:18:58 - WOPRAI, Judah Frommer
  Print publication without navigation


Judah Frommer of Credit Suisse, Initiated "Acumen Pharmaceuticals, Inc." (ABOS) at Buy and Held Target at $26 on, Jul 26th, 2021.

Judah, nor any peers, have made any analyst calls on ABOS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources